Quick answer: No FDA-approved drug contains BPC-157 or TB-500 as of 2026-10-09. Forum claims about the pair fall into about a dozen recurring types. None of the twelve we graded reaches "Human trials support". Most are "Animal or lab studies only" or "No published support found", and one, that FDA has approved the pair for compounding, is contradicted by FDA's own pages. This page grades each claim type.
If you found BPC-157 and TB-500 on Reddit or another forum, you met a set of claims that repeat from thread to thread. This page does not quote or name any post or user. It describes the claim types, says who tends to make each, says what the published record supports, and gives each one a grade from a fixed five-level key.
How we built this ledger
We could not open forum threads reliably for this project, so this is a map of claim types, not a counted sample of posts. We built it from two kinds of source: the "commonly reported" benefits listed on a peptide-education page, and the claims that clinic pages, news articles and health-publisher pages repeat or answer. Where we say "forums", we mean the type of claim, not any specific community. Each claim is then compared with the published record: human trials, animal studies, registered trials and FDA pages, all dated.
The grade key is fixed, from strongest to weakest: Human trials support, Small human reports only, Animal or lab studies only, No published support found, Contradicted by sources. A grade describes the published record. It says nothing about whether a person's own experience was real.
How these claims spread
The same few claims move between places, and each step adds confidence without adding evidence.
- Animal studies become headlines. A rat study reports faster tendon strength gains. A forum post summarizes it as "it repairs tendons". The species and the measure disappear.
- Clinic and shop pages repeat the summary. Pages that sell visits or products cite the same animal papers, and add language such as "synergistic" or "systemic". These pages are claims, not evidence, and a few say so about their own products: one concedes that neither peptide is approved as a drug.
- Personal reports fill the gap. In the absence of human trials, people share experiences. An experience can be true and still not show that a compound caused the change. One health-publisher page calls reports of human use "purely anecdotal", and an Australian health information page says most information comes from blog posts and anecdotes.
- Names do some of the work. The "Wolverine" label borrows the film character's fast recovery. An Australian health page calls it "a marketing term, not a scientific one". See the Wolverine peptide stack page for how different sources define it.
- Add-ons stack up. If two compounds are good, the reasoning goes, three or four must be better. Blends with names like Glow and Klow follow this logic. See the Glow and Klow page.
Why does this matter? A claim that has been repeated many times feels established. The ledger below checks each one against the record instead.
The graded claim ledger
| Claim as marketed | Who says it | What supports it | Grade |
|---|---|---|---|
| "It speeds up tendon and ligament repair" | Forum posts; clinic and shop pages | Rat studies, mostly from one Zagreb group; one independent rat study where TB-500 alone, not BPC-157 alone, reached significance on main scores; no human tendon trial found | Animal or lab studies only |
| "It cuts joint pain and stiffness, even in long-running cases" | Forum posts; education pages | One uncontrolled chart review of 16 people with knee pain at a private clinic, phone follow-up, no validated measure; no controlled trial | Small human reports only |
| "TB-500 works throughout the system while BPC-157 works at the injury site" | Clinic pages | Marketing description; we found no study that tests this split in people | No published support found |
| "Together they beat either one alone" | Clinic pages; forum posts | The only direct test, in rats, reports no added benefit over either agent alone, with one score favoring the pair | Animal or lab studies only |
| "Faster recovery after surgery, sprains and strains" | Forum posts; clinic pages | Rat muscle and tendon studies; two registered human studies (hamstring strain, rotator cuff repair) with no results posted | Animal or lab studies only |
| "It helps the gut as a bonus" | Forum posts; education pages | Rat studies of gut injury, mostly from the Zagreb group; no published human trial in any gut disease found | Animal or lab studies only |
| "Better sleep and more energy" | Forum posts | No study measuring sleep or energy in people given either compound found | No published support found |
| "Side effects are mild and short-lived" | Forum posts; clinic pages | About 30 people across three uncontrolled pilot reports; two say no adverse events were reported and the third does not describe any; reviews say no clinical safety data were found and FDA says human risks are unknown | Small human reports only |
| "My vial's lab report proves it is pure and correct" | Forum posts; online sellers | No standard supports this as proof; reviews warn of contamination and unverifiable manufacturing | No published support found |
| "It worked for me when nothing else did" | Forum posts | Personal accounts without imaging, comparison or blinding; cannot separate a compound from time, rest or expectation | No published support found |
| "FDA has approved them for compounding now" | One health-publisher page; some clinic pages | FDA's page, current as of 2026-04-22, lists both as "nominated but withdrawn"; no FDA final decision found as of 2026-10-09 | Contradicted by sources |
| "Add GHK-Cu, KPV or a growth-hormone peptide for better results" | Clinic pages; newsletter posts | No human trial of any such blend found; no controlled human trial of injected GHK-Cu found | No published support found |
As of 2026-10-09. A grade is not a verdict on safety or a recommendation.
Notes on the claims that come up most
Tendon repair. This is the central claim and it has the most animal data. The rat studies are real, and they are rat studies. See the BPC-157 page and the TB-500 page for the details, and note that the independent 2026 rat Achilles study did not find BPC-157 alone significant on total tendon scores.
Joint pain. The single human report is small, uncontrolled and from one clinic setting. Reviews describe the human data on BPC-157 as three pilot studies in total, with about 30 people between them. That is not enough to grade a claim higher.
Side effects. The phrase "mild and short-lived" comes from people's own reports. FDA's briefing for its advisory committee says the potential safety risks of TB-500 in humans are unknown, and FDA cites immunogenicity and peptide impurities as concerns on its bulk-substances page. The absence of reported harm in a few people is not the same as a finding of safety. Our side effects page sets out what is documented.
The approval claim. The only claim we graded "Contradicted by sources" rests on a dated check. The FDA page listing the pair as "nominated but withdrawn" was current as of 2026-04-22. FDA's advisory committee met on 2026-07-23; its meeting page, current as of 2026-08-06, posts briefing documents but no vote summary, and the committee is advisory. News outlets reported a narrow vote, which FDA's page did not confirm. We found no final FDA decision as of 2026-10-09. Check FDA's pages for anything newer, and see the legal status page for the full account.
A claim we leave out on purpose
Forum threads also trade amounts, timing and technique. We do not summarize those, grade them or link to them. No source we read supports a safe or standard human regimen, and a 2026 review states there is no validated dosing regimen for BPC-157. Our pages on why no safe dose is set, the dosing chart and the calculator question explain why we publish none.
Reading the ledger
Take a claim you have seen and find its row. Check the grade, then the "what supports it" cell. If the support is a species or study design that does not match the claim, the claim is ahead of the evidence. The benefits page grades each claimed benefit in more detail, and TB-500 vs BPC-157 compares the two compounds. The home page lists every guide. For any decision about your own care, talk to a licensed clinician.
Sources
- FDA: Certain bulk drug substances for use in compounding that may present significant safety risks page current as of 2026-04-22, read 2026-10-09
- FDA: July 23-24, 2026 meeting of the Pharmacy Compounding Advisory Committee page current as of 2026-08-06, read 2026-10-09
- FDA briefing document: TB-500 read 2026-10-09
- Lee and Padgett 2021, Alternative Therapies in Health and Medicine PMID 34324435
- Bicer et al. 2026, Joint Diseases and Related Surgery PMID 42542926
- Vasireddi et al. 2025, HSS Journal PMID 40756949
- McGuire et al. 2025, Current Reviews in Musculoskeletal Medicine PMID 40789979
- Mateescu et al. 2026, Pharmaceutics PMID 42198317
- Mendias and Awan 2026, Sports Medicine PMID 41966639
- AJSM 2026 primer on injectable peptide therapy PMID 41476424
- ClinicalTrials.gov NCT07437547 read 2026-10-09
- ClinicalTrials.gov NCT07803250 read 2026-10-09
FAQ
Are the claims on Reddit about BPC-157 and TB-500 true?
Some rest on real animal studies, and some on nothing we could find. Our ledger grades twelve recurring claim types. None reaches "Human trials support".
Why do forum users report good results if there are no trials?
People report what they experienced, and many things change an outcome at the same time, including rest, time and expectation. Without a comparison group, a personal report cannot separate those from a compound.
Did FDA approve BPC-157 and TB-500 in 2026?
No. No FDA-approved drug contains either as of 2026-10-09. FDA's page lists both as "nominated but withdrawn", and its advisory committee's meeting page posts briefing documents but no final decision.
Is there a safe dose people agree on?
No source we read supports one, and a 2026 review states there is no validated dosing regimen for BPC-157. Posts that give amounts are claims, not guidance.
Do clinic pages count as evidence?
No. A clinic or shop page selling a visit or a product is a source of claims. We attribute those claims and do not count them as evidence.
What should I bring to a clinician?
The claim you read, the source it came from and the product's label. Ask which evidence supports your specific use.
Not medical advice. See the medical disclaimer.
